In addition, total spike-specific CD4+ T cells were significantly higher in recovered individuals who had COVID-19 than in naive individuals until the administration of the second vaccine dose, while they became comparable at month 1 and remained similar also at month 8. This evidence concerns the gene CD4 and COVID-19.